Share Repurchases Delivered NAV Accretion
Repurchased ~412k shares in Q1 at a weighted-average price of $7.31 (plus ~210k additional shares subsequent to quarter end). Q1 repurchases were accretive to NAV by ~$0.08 per share; cumulative buybacks since program inception have contributed ~ $0.31 per share of NAV accretion.
Maintained Base Distribution and Supportive Fee Waiver
Board declared Q2 base distribution of $0.25 per share and paid a supplemental $0.01 in Q1. Adviser extended temporary voluntary incentive fee waiver reducing the applicable fee rate from 20% to 17.5% for 2026 to support distributable earnings.
STRS JV Remains Accretive and Scaled
STRS JV fair value $327.1M with average effective yield of 9.9% and generated ~$3.6M of income in Q1 (low‑teens ROE for the BDC's equity investment). Two new deals and two existing investments totaling $18.9M transferred to the JV in Q1; JV leverage 1.08x.
High Quality Collateral Mix and Concentration Metrics
98.8% of debt portfolio is first‑lien, senior secured. Non‑sponsor exposure represented ~38% of the portfolio at fair value. Risk ratings improved with ~88.3% of positions carrying a 1 or 2 rating (up from 85.9% prior quarter).
Strong Liquidity and Regulatory Coverage
Cash resources of ~$49.4M at quarter end (including ~$37.6M restricted). Asset coverage ratio of 176.2%, above the 150% regulatory minimum. Net effective debt-to-equity ratio improved to 1.12x (from 1.15x).
Disciplined Originations with Conservative Structure
Gross capital deployments of $25.4M in Q1 (three new originations totaling $18.5M, all first-lien loans, average leverage ~5.5x EBITDA). Focus on structure and credit quality amid competitive pricing; non-sponsor deals targeted at SOFR+600+.
Recovering Deal Flow and Pricing Advantages
Management reported a recent pickup in deal flow and higher pricing across the market (pricing up ~25–100 bps across segments). Company is focused on mid- and upper-mid market where structures appear more conservative and attractive.